Humana 2010 Annual Report Download - page 145

Download and view the complete annual report

Please find page 145 of the 2010 Humana annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 152

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152

Humana Inc.
SCHEDULE I—PARENT COMPANY FINANCIAL INFORMATION
CONDENSED STATEMENTS OF CASH FLOWS
For the year ended December 31,
2010 2009 2008
(in thousands)
Net cash provided by operating activities $ 1,219,361 $ 911,090 $ 547,813
Cash flows from investing activities:
Acquisitions ........................................... (839,642) (5,867) (341,288)
Purchases of investment securities .......................... (633,039) (597,858) (7,528)
Proceeds from sale of investment securities .................. 15,585 2,309 28,868
Maturities of investment securities ......................... 697,284 278,443 2,489
Purchases of property and equipment, net .................... (165,864) (142,931) (195,517)
Capital contributions to operating subsidiaries ................ (230,000) (132,257) (467,750)
Change in securities lending collateral ...................... 952 0 400,292
Net cash used in investing activities .................... (1,154,724) (598,161) (580,434)
Cash flows from financing activities:
Borrowings under credit agreement ......................... 0 0 1,175,000
Repayments under credit agreement ........................ 0 (250,000) (1,725,000)
Proceeds from issuance of senior notes ...................... 0 0 749,247
Debt issue costs ........................................ (7,777) 0 (6,696)
Proceeds from swap termination ........................... 0 0 93,008
Change in book overdraft ................................. 1,535 34,264 (27,720)
Change in securities lending payable ........................ (952) 0 (400,292)
Common stock repurchases ............................... (108,545) (22,841) (106,070)
Tax benefit from stock-based compensation .................. 1,964 5,339 9,912
Proceeds from stock option exercises and other ............... 17,791 17,040 10,965
Net cash used in financing activities .................... (95,984) (216,198) (227,646)
(Decrease) increase in cash and cash equivalents .................. (31,347) 96,731 (260,267)
Cash and cash equivalents at beginning of year .................... 345,792 249,061 509,328
Cash and cash equivalents at end of year ......................... $ 314,445 $ 345,792 $ 249,061
See accompanying notes to the parent company financial statements.
135